Thrombolytic therapy for noncoronary diseases.

Area of Science:

• Cardiovascular Medicine
• Vascular Surgery
• Interventional Radiology

Background:

• Thrombolytic therapy is established for acute thrombotic events.
• It offers a favorable benefit-to-risk ratio when indications are met.
• Successful thrombolysis can prevent long-term pathological changes and complications.

Purpose of the Study:

• To review the efficacy and applications of thrombolytic therapy.
• To highlight its role in managing deep-vein thrombophlebitis, pulmonary embolism, and arterial thrombosis.
• To discuss the experimental use of thrombolysis in acute stroke.

Main Methods:

• Review of existing literature on thrombolytic therapy.
• Analysis of clinical outcomes in various thrombotic conditions.
• Evaluation of the risk-benefit profile in different patient populations.

Main Results:

• Thrombolysis prevents postphlebitic syndrome in deep-vein thrombophlebitis.
• It reduces morbidity and prevents chronic pulmonary hypertension in acute pulmonary embolism.
• Restores arterial flow, limits ischemic damage, and supplements angioplasty/surgery.
• Stroke treatment remains experimental due to reperfusion bleeding risks.

Conclusions:

• Thrombolytic therapy is an effective adjunct for acute thrombotic disorders.
• Early intervention is crucial for optimal outcomes and complication prevention.
• Further research is needed to establish its role in acute stroke management.